German protein technology specialist Cube Biotech has announced a significant leadership transition, appointing Michael Bencak as Chief Executive Officer whilst founder Didier Dargent assumes the Executive Chairman position. The strategic move positions the company for accelerated global expansion in drug discovery technologies.
Austrian biotech HeartBeat.bio has partnered with German AI company biotx.ai to identify and validate novel therapeutic targets for heart failure treatment. The collaboration integrates biotx.ai’s genome-wide causal mapping platform with HeartBeat.bio’s human cardiac organoid technology, aiming to accelerate precision medicine development for the 30 million patients affected globally.
BioMed X and Servier have established the first XSeed Labs facility in Europe at the Spartners incubator in Paris-Saclay. The collaboration will develop an AI-empowered platform for sterically guided design of bispecific antibodies, addressing critical constraints in cancer immunotherapy development.
EUROIMMUN (part of Revvity) has added 23 new assays to its portfolio of indirect immunofluorescence assays (IFA) for use on the UNIQO 160, its all-in-one instrument for walkway IFA automation. The new assays extend existing panels for autoantibody diagnostics in rheumatology, vasculitis, hepatology and gastroenterology.
Iron deficiency and iron deficiency anemia are remarkably common worldwide. However, recommended ferritin cut-off concentrations can vary widely and there is room for improvement in standardization across different assay platforms. Dr Katie Troike and Dr Adam McShane (Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA) recently conducted their own re-evaluation of ferritin […]
High performance solution for advanced urine determination
The on-demand solution that saves more than time.
The Modern Critical Care Profile Prime Plus provides the most clinical value of any blood gas/critical care analyzer by adding essential tests for kidney function (BUN, Creatinine, eGFR), plasma volume (ePV), ionized magnesium (iMg) and MCHC.
A comprehensive review of diagnostic and monitoring strategies Delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage is a multifactorial syndrome extending beyond large-vessel vasospasm. This review explores the evolving diagnostic and monitoring landscape, emphasizing a shift toward multimodal monitoring techniques that detect microcirculatory failure, spreading depolarizations, and metabolic distress.
Assessment of minimal residual disease during B-cell precursor acute lymphoblastic leukemia provides a good indication of therapy response and prognosis. This investigation can be done in several ways, including flow cytometry. Techniques in this field have developed in recent years and CLI chatted to Dr van der Velden (Department of Immunology, Erasmus University Medical Center, […]
March 2026
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.